Fever-Tree’s US expansion undeterred by Trump’s tariffs

Fever-Tree

Fever-Tree sold an 8.5% stake to Molson Coors in January as part of a strategic partnership to expand across the US

Fever-Tree’s US expansion plans will not be affected by US tariffs as the impact will eventually be mitigated by the onshoring of production inside the country, the business has said.

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW